Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125600201 | 12560020 | 1 | I | 20160624 | 0 | 20160714 | 20160714 | DIR | 99.00 | YR | M | N | 69.00000 | KG | 20160706 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125600201 | 12560020 | 1 | PS | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | Y | D | 0 | 120 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125600201 | 12560020 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125600201 | 12560020 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125600201 | 12560020 | Accidental overdose | |
| 125600201 | 12560020 | Acute kidney injury | |
| 125600201 | 12560020 | Bradycardia | |
| 125600201 | 12560020 | Dyspnoea | |
| 125600201 | 12560020 | Fatigue | |
| 125600201 | 12560020 | Hyperkalaemia | |
| 125600201 | 12560020 | Oedema peripheral | |
| 125600201 | 12560020 | Palpitations | |
| 125600201 | 12560020 | Renal tubular necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125600201 | 12560020 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125600201 | 12560020 | 1 | 20160617 | 20160624 | 0 |